Tissue factor‐bearing microparticles derived from tumor cells: impact on coagulation activation
- 1 September 2008
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (9) , 1517-1524
- https://doi.org/10.1111/j.1538-7836.2008.02987.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Risk of venous thromboembolism in lung cancerCurrent Opinion in Pulmonary Medicine, 2007
- Cancer-associated thrombosisCritical Reviews in Oncology/Hematology, 2007
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007
- Microvesicle‐associated tissue factor and Trousseau's syndromeJournal of Thrombosis and Haemostasis, 2006
- Evidence for Activation of Tissue Factor by an Allosteric Disulfide BondBiochemistry, 2006
- Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexesThrombosis Journal, 2005
- Membrane Microparticles: Two Sides of the CoinPhysiology, 2005
- Shedding of tissue factor (TF)‐containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cellsJournal of Thrombosis and Haemostasis, 2004
- Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic proteinNature Medicine, 2003
- Low levels of tissue factor are compatible with development and hemostasis in mice.Journal of Clinical Investigation, 1998